Table of Contents
International Journal of Molecular Imaging
Volume 2015 (2015), Article ID 916016, 6 pages
http://dx.doi.org/10.1155/2015/916016
Clinical Study

Seasonal Temperature Changes Do Not Affect Cardiac Glucose Metabolism

Department of Nuclear Medicine, HUS Medical Imaging Center, Helsinki University Central Hospital, Haartmaninkatu 4, 00029 Helsinki, Finland

Received 14 October 2015; Accepted 14 December 2015

Academic Editor: Adriaan A. Lammertsma

Copyright © 2015 Jukka Schildt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Meller, C.-O. Sahlmann, and A. K. Scheel, “18F-FDG PET and PET/CT in fever of unknown origin,” Journal of Nuclear Medicine, vol. 48, no. 1, pp. 35–45, 2007. View at Google Scholar · View at Scopus
  2. E. D. Abel, “Glucose transport in the heart,” Frontiers in Bioscience, vol. 9, pp. 201–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Williams and G. M. Kolodny, “Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet,” American Journal of Roentgenology, vol. 190, no. 2, pp. W151–W156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. W. C. Stanley, G. D. Lopaschuk, J. L. Hall, and J. G. McCormack, “Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions,” Cardiovascular Research, vol. 33, no. 2, pp. 243–257, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. H. Khandani, C. R. Isasi, and M. D. Blaufox, “Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET,” Nuclear Medicine Communications, vol. 26, no. 9, pp. 787–791, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Inglese, L. Leva, R. Matheoud et al., “Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT,” Journal of Nuclear Medicine, vol. 48, no. 10, pp. 1662–1669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Silverman, G. M. Hutchins, and B. H. Bulkley, “Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis,” Circulation, vol. 58, no. 6, pp. 1204–1211, 1978. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Ardehali, D. L. Howard, A. Hariri et al., “A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy,” American Heart Journal, vol. 150, no. 3, pp. 459–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Skali, A. R. Schulman, and S. Dorbala, “18F-FDG PET/CT for the assessment of myocardial sarcoidosis,” Current Cardiology Reports, vol. 15, no. 4, article 352, 2013. View at Google Scholar
  10. S. Ishimaru, I. Tsujino, T. Takei et al., “Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis,” European Heart Journal, vol. 26, no. 15, pp. 1538–1543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Tahara, A. Tahara, Y. Nitta et al., “Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis,” JACC: Cardiovascular Imaging, vol. 3, no. 12, pp. 1219–1228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Cerqueira, N. J. Weissman, V. Dilsizian et al., “Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association,” Circulation, vol. 105, pp. 539–542, 2002. View at Google Scholar
  13. S. V. Nesterov, C. Han, M. Mäki et al., “Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas),” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 10, pp. 1594–1602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Lobert, R. K. J. Brown, R. A. Dvorak, J. R. Corbett, E. A. Kazerooni, and K. K. Wong, “Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT,” Clinical Radiology, vol. 68, no. 1, pp. e59–e71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kaneta, T. Hakamatsuka, K. Takanami et al., “Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization,” Annals of Nuclear Medicine, vol. 20, no. 3, pp. 203–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Okumura, T. Iwasaki, T. Toyama et al., “Usefulness of fasting18 F-FDG PET in identification of cardiac sarcoidosis,” Journal of Nuclear Medicine, vol. 45, no. 12, pp. 1989–1998, 2004. View at Google Scholar · View at Scopus
  17. R. Langah, K. Spicer, M. Gebregziabher, and L. Gordon, “Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis,” Journal of Nuclear Cardiology, vol. 16, no. 5, pp. 801–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Ouellet, A. Routhier-Labadie, W. Bellemare et al., “Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 1, pp. 192–199, 2011. View at Publisher · View at Google Scholar · View at Scopus